← All trials
NCT03942354
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2019
- Primary completion
- Dec 31, 2020
- Completion date
- Mar 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 54
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Medecins Sans FrontieresLead sponsor
- University of LondonCollaborator
- University of SussexCollaborator
- Republican TB Hospital No. 2, NukusCollaborator
- Republican specialised scientific-practical medical centre, TashkentCollaborator
- Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospitalCollaborator
- Medecins Sans FrontieresOverall official - principal investigator
- Doris Goodwin Hospitals, Kwazulu Natal, South AfricaCollaborator
- Don McKenzie Hospitals, Kwazulu Natal, South AfricaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.